These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17613417)

  • 1. Trabectedin--a targeted chemotherapy?
    von Mehren M
    Lancet Oncol; 2007 Jul; 8(7):565-7. PubMed ID: 17613417
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.
    Grosso F; Jones RL; Demetri GD; Judson IR; Blay JY; Le Cesne A; Sanfilippo R; Casieri P; Collini P; Dileo P; Spreafico C; Stacchiotti S; Tamborini E; Tercero JC; Jimeno J; D'Incalci M; Gronchi A; Fletcher JA; Pilotti S; Casali PG
    Lancet Oncol; 2007 Jul; 8(7):595-602. PubMed ID: 17586092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.
    D'Incalci M; Badri N; Galmarini CM; Allavena P
    Br J Cancer; 2014 Aug; 111(4):646-50. PubMed ID: 24755886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete response of a recurrent-metastatic liposarcoma with dedifferentiated histological features following the administration of trabectedin and review of literature.
    Kus T; Aktas G; Kalender ME; Tutar E; Ulker E; Camci C
    J Cancer Res Ther; 2015; 11(4):974-6. PubMed ID: 26881560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcoma.
    Uboldi S; Calura E; Beltrame L; Fuso Nerini I; Marchini S; Cavalieri D; Erba E; Chiorino G; Ostano P; D'Angelo D; D'Incalci M; Romualdi C
    PLoS One; 2012; 7(4):e35423. PubMed ID: 22523595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intriguing patterns of tumor response to trabectedin.
    Sanfilippo R; Casali PG
    Expert Rev Anticancer Ther; 2013 Jun; 13(6 Suppl 1):21-4. PubMed ID: 23638727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma.
    Gronchi A; Bui BN; Bonvalot S; Pilotti S; Ferrari S; Hohenberger P; Hohl RJ; Demetri GD; Le Cesne A; Lardelli P; Pérez I; Nieto A; Tercero JC; Alfaro V; Tamborini E; Blay JY
    Ann Oncol; 2012 Mar; 23(3):771-776. PubMed ID: 21642514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
    Uboldi S; Bernasconi S; Romano M; Marchini S; Fuso Nerini I; Damia G; Ganzinelli M; Marangon E; Sala F; Clivio L; Chiorino G; Di Giandomenico S; Rocchi M; Capozzi O; Margison GP; Watson AJ; Caccuri AM; Pastore A; Fossati A; Mantovani R; Grosso F; Tercero JC; Erba E; D'Incalci M
    Int J Cancer; 2012 Jul; 131(1):59-69. PubMed ID: 21805478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of trabectedin in myxoid liposarcomas.
    Di Giandomenico S; Frapolli R; Bello E; Uboldi S; Licandro SA; Marchini S; Beltrame L; Brich S; Mauro V; Tamborini E; Pilotti S; Casali PG; Grosso F; Sanfilippo R; Gronchi A; Mantovani R; Gatta R; Galmarini CM; Sousa-Faro JM; D'Incalci M
    Oncogene; 2014 Oct; 33(44):5201-10. PubMed ID: 24213580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of trabectedin for the treatment of liposarcoma.
    Zijoo R; von Mehren M
    Expert Opin Pharmacother; 2016 Oct; 17(14):1953-62. PubMed ID: 27615729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies.
    Takahashi M; Takahashi S; Araki N; Sugiura H; Ueda T; Yonemoto T; Morioka H; Hiraga H; Hiruma T; Kunisada T; Matsumine A; Shimura M; Kawai A
    Oncologist; 2017 Aug; 22(8):979-988. PubMed ID: 28526720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trabectedin.
    Chuk MK; Balis FM; Fox E
    Oncologist; 2009 Aug; 14(8):794-9. PubMed ID: 19684073
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel models of myxoid liposarcoma xenografts mimicking the biological and pharmacologic features of human tumors.
    Frapolli R; Tamborini E; Virdis E; Bello E; Tarantino E; Marchini S; Grosso F; Sanfilippo R; Gronchi A; Tercero JC; Peloso G; Casali P; Pilotti S; D'Incalci M
    Clin Cancer Res; 2010 Oct; 16(20):4958-67. PubMed ID: 20732964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trabectedin and ovarian cancer: statistical trickery.
    Prescrire Int; 2011 Apr; 20(115):93. PubMed ID: 21648209
    [No Abstract]   [Full Text] [Related]  

  • 15. Trabectedin in ovarian cancer: could we expect more?
    Sessa C; D'Incalci M
    Ann Oncol; 2011 Jan; 22(1):7-8. PubMed ID: 21059638
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.
    Germano G; Frapolli R; Simone M; Tavecchio M; Erba E; Pesce S; Pasqualini F; Grosso F; Sanfilippo R; Casali PG; Gronchi A; Virdis E; Tarantino E; Pilotti S; Greco A; Nebuloni M; Galmarini CM; Tercero JC; Mantovani A; D'Incalci M; Allavena P
    Cancer Res; 2010 Mar; 70(6):2235-44. PubMed ID: 20215499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of trabectedin for the treatment of liposarcoma or leiomyosarcoma.
    Saponara M; Stacchiotti S; Gronchi A
    Expert Rev Anticancer Ther; 2016 May; 16(5):473-84. PubMed ID: 27043847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trabectedin therapy for sarcomas.
    Casali PG; Sanfilippo R; D'Incalci M
    Curr Opin Oncol; 2010 Jul; 22(4):342-6. PubMed ID: 20489618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
    Morioka H; Takahashi S; Araki N; Sugiura H; Ueda T; Takahashi M; Yonemoto T; Hiraga H; Hiruma T; Kunisada T; Matsumine A; Susa M; Nakayama R; Nishimoto K; Kikuta K; Horiuchi K; Kawai A
    BMC Cancer; 2016 Jul; 16():479. PubMed ID: 27418251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trabectedin and ovarian cancer (continued).
    Prescrire Int; 2011 Oct; 20(120):249-50. PubMed ID: 21970099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.